In Other News

• Gut Microbiome Test Predicts Melanoma Recurrence After Surgery

• AI Pathology Model Predicts Immunotherapy Response in Lung Cancer

• Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma

• Gut Microbiome Test Predicts Melanoma Recurrence After Surgery

• Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

• Blood Test Enables Early Detection and Classification of Glioma

• Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

• Rapid Blood-Culture Susceptibility Panel Expands Coverage for Gram-Negative Infections

• QuidelOrtho Adds Ultra-Fast PCR Platform with LEX Acquisition

• Antibiotic Resistance Genes Found in Newborns Within Hours of Birth

• Multi-Biomarker Blood Test Detects Early-Stage Cancers Across Types

• New Sample-to-Answer PCR System Supports High-Throughput Infectious Disease Testing

• Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID

• Seegene Showcases Real-Time PCR Data Analytics Platform at ESCMID

• Immune Aging Clock Quantifies Immunosenescence and Identifies Therapeutic Target

• Framework Guides Targeted Immunotherapy Selection in Liver Cancer

• Collaboration Brings Rapid At-Home STI Testing with Virtual Follow-Up

• AI Precision Tests Deliver Cancer Risk Insights from Routine H&E Slides

• mNGS CSF Test Identifies CNS Pathogens Missed by Standard Panels

• Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

• Study Reveals Moleclar Mechanism Driving Aggressive Skin Cancer

• Framework Guides Targeted and Immunotherapy Selection in Liver Cancer

• Collaboration Brings Rapid At-Home STI Testing with Virtual Follow-Up